W T Beck Selected Research

Polypyrimidine Tract-Binding Protein

1/2014	Involvement of polypyrimidine tract-binding protein (PTBP1) in maintaining breast cancer cell growth and malignant properties.
1/2011	Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer.
7/2007	Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

W T Beck Research Topics

Disease

6	Neoplasms (Cancer) 01/2014 - 05/2000
3	Ovarian Neoplasms (Ovarian Cancer) 01/2014 - 08/2001
1	Breast Neoplasms (Breast Cancer) 01/2014
1	Ovarian Epithelial Carcinoma 01/2011
1	Leukemia 08/2001

Drug/Important Bio-Agent (IBA)

3	Polypyrimidine Tract-Binding ProteinIBA 01/2014 - 07/2007
2	RNA Splicing FactorsIBA 01/2014 - 01/2011
2	AgarIBA 01/2014 - 01/2011
2	trioctyl phosphine oxide (TOPO)IBA 02/2001 - 05/2000
1	Small Interfering RNA (siRNA)IBA 07/2007
1	Doxycycline (Periostat)FDA LinkGeneric 07/2007
1	phosphoramiditeIBA 08/2001
1	PlatinumIBA 08/2001
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 02/2001
1	Proteins (Proteins, Gene)FDA Link 05/2000
1	Topotecan (Hycamtin)FDA LinkGeneric 05/2000
1	Pharmaceutical PreparationsIBA 05/2000